drug

MNV-201

Phase 2updated 3mo ago

by Minovia Therapeutics Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying MNV-201

phase1A Study to Evaluate the MNV-201 in Patients With Low Risk MDSrecruitingn=15
phase2Evaluate the Safety and Therapeutic Effects of a Single Intravenous Infusion (IV) of Autologous CD34+ Cells Enriched With Allogenic Placenta-derived Mitochondria in Patients With a Diagnosis of Pearson Syndrome (PS)recruitingn=6

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

MNV-201

Phase 2updated 3mo ago

by Minovia Therapeutics Ltd

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying MNV-201

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

MNV-201

all catalysts(0)

Trials studying MNV-201

News(0)

Report a data issue

comments(0)

MNV-201

all catalysts(0)

Trials studying MNV-201

News(0)

Report a data issue

comments(0)